Angiotensin II Signaling in Human Preadipose Cells: Participation of ERK1,2-Dependent Modulation of Akt

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Dünner, Natalia ^a   Quezada, Carolina ^a,b   Berndt, F Andrés ^a   Cánovas, José ^a   Rojas, Cecilia V ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR O1; FORKHEAD TRANSCRIPTION FACTOR O4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SERINE PROTEINASE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANGIOTENSIN II; ENZYME ACTIVATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84884879266     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075440     Document Type: Article

References (65)

1. Schling P, Mallow H, Trindl A, Loffler G, (1999) Evidence for a local renin angiotensin system in primary cultured human preadipocytes. Int J Obes Relat Metab Disord 23: 336-341.
2. Dusserre E, Moulin P, Vidal H, (2000) Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500: 88-96.
3. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, et al. (2002) Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15: 381-388.
4. Rahmouni K, Mark AL, Haynes WG, Sigmund CD, (2004) Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. Am J Physiol Endocrinol Metab 286: E891-E895.
5. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, et al. (2000) Increased adipose angiotensinogen gene expression in human obesity. Obes Res 8: 337-341.
6. Van Harmelen V, Elizalde M, Ariapart P, Bergstedt-Lindqvist S, Reynisdottir S, et al. (2000b) The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 24: 673-678.
7. Yasue S, Masuzaki H, Okada S, Ishii T, Kozuka C, et al. (2010) Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am J Hypertens 23: 425-431.
8. Karlsson C, Lindell K, Ottosson MSJ, Sjöström L, Carlsson B, et al. (1998) Human adipose tissue express angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 83: 3925-3929.
9. Schling P, Schafer T, (2002) Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity. J Biol Chem 277: 48066-48075.
10. Santos RA, Ferreira AJ, Verano-Braga T, Bader M, (2013) Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol 216: R1-R17.
11. Kalupahana NS, Moustaid-Moussa N, (2012) The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms. Crit Rev Biochem Mol Biol 47: 379-90.
12. Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, et al. (2001) Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15: 2727-2729.
13. Brücher R, Cifuentes M, Albala C, Rojas CV, (2007) Angiotensin II reduces adipogenic differentiation of adipocytes precursor cells from human omental adipose tissue. Obesity 15: 1643-1646.
14. Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma A, (2002) Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 51: 1699-1701.
15. Schling P, Loffler G, (2001) Effects of angiotensin II on adipose conversion and expression of genes of the renin angiotensin system in human preadipocytes. Horm Metab Res 33: 189-195.
16. Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ, (2006) Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 48: 1095-1102.
17. Tchkonia T, Giorgadze N, Pirtskhalava T, Tchoukalova Y, Karagiannides I, et al. (2002) Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol 282: R1286-R1296.
18. Tchkonia T, Tchoukalova YD, Giorgadze N, Pirtskhalava T, Karagiannides I, et al. (2005) Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab 288: E267-E277.
19. Tomono Y, Iwai M, Inaba S, Mogi M, Horiuchi M, (2008) Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models. Am J Hypertens 21: 206-212.
20. Iwai M, Tomono Y, Inaba S, Kanno H, Senba H, et al. (2009) AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am J Hypertens 22: 784-791.
21. Ye ZW, Wu XM, Jiang JG, (2009) Expression changes of angiotensin II pathways and bioactive mediators during human preadipocytes-visceral differentiation. Metabolism 58: 1288-1296.
22. Crandall DL, Herzlinger HE, Saunders BD, Armellino DC, Kral JG, (1994) Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res 35: 1378-1385.
23. Crandall DL, Armellino DC, Busler DE, McHendry-Rinde B, Kral JG, (1999) Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 140: 154-158.
24. Nguyen Dinh Cat A, Touyz RM, (2011) Cell of angiotensin II on vascular tone: novel mechanisms. Curr Hypertens Rep 13: 122-128.
25. Patel CB, Noor N, Rockman HA, (2010) Functional selectivity in adrenergic and angiotensin systems. Mol Pharmacol 78: 983-992.
26. Shah BH, (2002) Epidermal growth factor receptor transactivation in angiotensin II induced signaling: role of cholesterol-rich microdomains. Trends Endocrinol Metab 13: 1-2.
27. Cook JL, Re RN, (2012) Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model. Am J Physiol Regul Integr Comp Physiol 302: R482-R493.
28. Gwathmey TM, Alzayadneh EM, Pendergrass KD, Chappell MC, (2012) Novel roles of nuclear angiotensin receptors and mechanisms. Am J Physiol Regul Integr Comp Physiol 302: R518-R530.
29. Fuentes P, Acuña MJ, Cifuentes M, Rojas CV, (2010) The anti-adipogenic effect of angiotensin II on human preadipose cells depends on MEK/ERK1,2 activation and phosphorylation. J Endocrinol 206: 75-83.
30. Albinsson S, Hellstrand P, (2007) Integration of signal pathways for stretch-dependent growth and differentiation in vascular smooth muscle. Am J Physiol Cell Physiol 293: C772-C782.
31. Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G, (2004) Angiotensin II impairs the insulin pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res 94: 1211-1218.
32. Arellano-Plancarte A, Hernández-Aranda J, Catt KJ, Olivares-Reyes JA, (2010) Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells. Biochem Pharmacol 79: 733-745.
33. Khundmiri SJ, Amin V, Henson J, Lewis J, Ameen M, et al. (2007) Ouabain stimulates protein kinase B (Akt) phosphorylation in opossum kidney proximal tubule cells through an ERK-dependent pathway. Am J Physiol Cell Physiol 293: C1171-C1180.
34. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, et al. (2006) Modulation of the Akt/Ras/Raf/MEK/ERK pathway by A (3) adenosine receptor. Purinergic Signal 2: 627-632.
35. Sinha D, Bannergee S, Schwartz JH, Lieberthal W, Levine JS, (2004) Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis. J Biol Chem 279: 10962-10972.
36. Yang S-J, Chang S-C, Wen H-C, Chen C-Y, Lia J-F, et al. (2010) Plumbagin activates ERK1/2 and Akt via superoxide, Src and PI3-kinase in 3T3-L1 Cells. Eur J Pharmacol 638: 21-28.
37. Bhattacharya I, Ullrich A, (2006) Endothelin-1 inhibits adipogenesis: role of phosphorylation of Akt and ERK1/2. FEBS Lett 580: 5765-5771.
38. Wang T, Wang Y, Kontani Y, Kobayashi Y, Sato Y, et al. (2008) Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling. Endocrinology 149: 358-366.
39. Kohn AD, Summers SA, Birnbaum MJ, Roth RA, (1996) Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 271: 31372-31378.
40. Magun R, Burgering BM, Coffer PJ, Pardasani D, Lin Y, et al. (1996) Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology 137: 3590-3593.
41. Yoshiga D, Sato N, Torisu T, Mori H, Yoshida R, et al. (2007) Adaptor protein SH2-B linking receptor-tyrosine kinase and Akt promotes adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma messenger ribonucleic acid levels. Mol Endocrinol 21: 1120-1131.
42. Yun SJ, Kim EK, Tucker DF, Kim CD, Birnbaum MJ, et al. (2008) Isoform-specific regulation of adipocytes differentiation by Akt/protein kinase B alpha. Biochem Biophys Res Commun 371: 138-43.
43. Wabitsch M, Brenner RE, Melzner I, Braun M, Möller P, et al. (2001) Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Internat J Obesity 25: 8-15.
44. Fisher-Posovsky P, Newell FS, Wabitsch M, Tornquist HE, (2008) Human SGBS cells - a unique tool for studies of human fat cell biology. Obesity Facts 1: 184-189.
45. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase Kinase. J Biol Chem 273: 18623-18632.
46. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR, (1995) PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494.
47. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR, (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92: 7686-7689.
48. Vantaggiato C, Formentini I, Bondanza A, Bonini C, Naldini L, et al. (2006) ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially. J Biol 5: 14.
49. Leal-Ortiz S, Waites CL, Terry-Lorenzo R, Zamorano P, Gundelfinger ED, et al. (2008) Piccolo modulation of Synapsin1a dynamics regulates synaptic vesicle exocitosis. J Cell Biol 181: 831-846.
50. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D, (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871-875.
51. Salmon P, Trono D (2006) Production and titration of lentiviral vectors. Curr Protoc Neurosci Chapter 4: Unit 4.21.
52. Bost F, Aouadi M, Caron L, Even P, Belmonte N, et al. (2005) The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 54: 402-411.
53. Fritsche L, Neukamm SS, Lehmann R, Kremmer E, Hennige AM, et al. (2011) Insulin-induced serine phosphorylation of IRS-2 via ERK1/2 and mTOR: studies on the function of Ser675 and Ser907. Am J Physiol Endocrinol Metab 300: E824-E836.
54. Nazarewicz RR, Salazar G, Patrushev N, San Martin A, Hilenski L, et al. (2011) Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-α-dependent Akt activation in endosomes. J Biol Chem 286: 2886-2895.
55. Hay N, (2011) Interplay between FOXO, TOR, and Akt. Biochim Biophys Acta 1813: 1965-1970.
56. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH, (2007) Hyperglycemia enhances adipogenic induction of lipid accumulation: involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling. Endocrinology 148: 4267-4275.
57. Punn A, Levine MA, Grammatopoulos DK, (2006) Identification of molecules mediating corticotropin-releasing hormone-R1α-mitogen-activated protein kinase (MAPK) interactions: the critical role of phosphatidylinositol 3-kinase in regulating ERK1/2 but not p38 MAPK activation. Mol Endocrinol 20: 3179-3195.
58. Tanski W, Roztocil E, Davies MG, (2002) Sphingosine-1-phosphate induces G (alphai)-coupled, PI3K/ras-dependent smooth muscle cell migration. J Surg Res 108: 98-106.
59. Lardizabal JA, Deedwania PC, (2010) The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Curr Cardiol Rep 12: 464-471.
60. Chai W, Wang W, Dong Z, Cao W, Liu Z, (2011) Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes 60: 2939-2946.
61. Csibi A, Communi D, Müller N, Bottari SP (2010) Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms. PLoS One 5, e10070.
62. Diamond-Stanic MK, Henriksen EJ, (2010) Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism. Arch Physiol Biochem 116: 88-95.
63. Hashikawa-Hobara N, Hashikawa N, Inoue Y, Sanda H, Zamami Y, et al. (2012) Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. Diabetes 61: 925-932.
64. Carvalho E, Eliasson B, Wesslau C, Smith U, (2000) Impaired phosphorylation and insulin-stimulated translocation to the plasma membrane of protein kinase B/Akt in adipocytes from type II diabetic subjects. Diabetologia 43: 1107-1115.
65. Cleveland-Donovan K, Maile LA, Tsiaras WG, Tchkonia T, Kirkland JL, et al. (2010) IGF-I activation of the Akt pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology 151: 3752-3763.